Your browser doesn't support javascript.
loading
EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease.
Dafsari, Haidar S; Martinez-Martin, Pablo; Rizos, Alexandra; Trost, Maja; Dos Santos Ghilardi, Maria Gabriela; Reddy, Prashanth; Sauerbier, Anna; Petry-Schmelzer, Jan Niklas; Kramberger, Milica; Borgemeester, Robbert W K; Barbe, Michael T; Ashkan, Keyoumars; Silverdale, Monty; Evans, Julian; Odin, Per; Fonoff, Erich Talamoni; Fink, Gereon R; Henriksen, Tove; Ebersbach, Georg; Pirtosek, Zvezdan; Visser-Vandewalle, Veerle; Antonini, Angelo; Timmermann, Lars; Ray Chaudhuri, K.
Affiliation
  • Dafsari HS; Department of Neurology, University Hospital Cologne, Cologne, Germany.
  • Martinez-Martin P; National Parkinson Foundation International Centre of Excellence, King's College Hospital, London, United Kingdom.
  • Rizos A; National Center of Epidemiology and CIBERNED, Carlos III Institute of Health, Madrid, Spain.
  • Trost M; National Parkinson Foundation International Centre of Excellence, King's College Hospital, London, United Kingdom.
  • Dos Santos Ghilardi MG; Department of Neurology, University Medical Center Ljubljana, Ljubljana, Slovenia.
  • Reddy P; Department of Neurology, Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil.
  • Sauerbier A; National Parkinson Foundation International Centre of Excellence, King's College Hospital, London, United Kingdom.
  • Petry-Schmelzer JN; National Parkinson Foundation International Centre of Excellence, King's College Hospital, London, United Kingdom.
  • Kramberger M; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
  • Borgemeester RWK; Department of Neurology, University Hospital Cologne, Cologne, Germany.
  • Barbe MT; Department of Neurology, University Medical Center Ljubljana, Ljubljana, Slovenia.
  • Ashkan K; Department of Neurology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Silverdale M; Department of Neurology, University Hospital Cologne, Cologne, Germany.
  • Evans J; National Parkinson Foundation International Centre of Excellence, King's College Hospital, London, United Kingdom.
  • Odin P; Department of Neurology and Neurosurgery, Salford Royal Foundation Trust, Manchester Academic Health Science Centre, University of Manchester, Greater Manchester, United Kingdom.
  • Fonoff ET; Department of Neurology and Neurosurgery, Salford Royal Foundation Trust, Manchester Academic Health Science Centre, University of Manchester, Greater Manchester, United Kingdom.
  • Fink GR; Department of Neurology, Klinikum-Bremerhaven, Bremerhaven, Germany.
  • Henriksen T; Department of Neurology, Skane University Hospital, Lund, Sweden.
  • Ebersbach G; Department of Neurology, Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil.
  • Pirtosek Z; Laboratory of Neuromodulation, Institute of Teaching and Research, Hospital Sirio-Libanês, São Paulo, Brazil.
  • Visser-Vandewalle V; Department of Neurology, University Hospital Cologne, Cologne, Germany.
  • Antonini A; Cognitive Neuroscience, Institute of Neuroscience and Medicine (INM-3), Research Centre Jülich, Jülich, Germany.
  • Timmermann L; Movement Disorder Clinic, University Hospital of Bispebjerg, Copenhagen, Denmark.
  • Ray Chaudhuri K; Movement Disorder Clinic, Kliniken Beelitz, Beelitz-Heilstätten, Germany.
Mov Disord ; 34(3): 353-365, 2019 03.
Article in En | MEDLINE | ID: mdl-30719763

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Apomorphine / Levodopa / Dopamine Agonists / Subthalamic Nucleus / Deep Brain Stimulation / Antiparkinson Agents Type of study: Clinical_trials / Observational_studies / Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Mov Disord Journal subject: NEUROLOGIA Year: 2019 Type: Article Affiliation country: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Apomorphine / Levodopa / Dopamine Agonists / Subthalamic Nucleus / Deep Brain Stimulation / Antiparkinson Agents Type of study: Clinical_trials / Observational_studies / Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Mov Disord Journal subject: NEUROLOGIA Year: 2019 Type: Article Affiliation country: Germany